Log in | Join Free | china | japan | germany

Dolutegravir-d6

Request For Quotation
Dolutegravir-d6 Suppliers list
Company Name: Nanjing Haolv Biotechnology Co.,Ltd  
Tel: 025-84622273 17361806303
Email: 3004208264@qq.com
Products Intro: Product Name:Dolutegravir-d6
CAS:1407166-95-3
Purity:98%D Package:5g;10g;25g
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Email: marketing@energy-chemical.com
Products Intro: Product Name:Dolutegravir-d6
CAS:1407166-95-3
Purity:NULL Package:0.5mg;1mg;2.5mg;5mg Remarks:NULL
Company Name: Changzhou Bojia Biomedical Technology Co., Ltd.  
Tel: 2122619822
Email: czbjpharma@126.com
Products Intro: CAS:1407166-95-3
Purity:98% Package:10g;100g;500g;1kg;5kg;10kg
Company Name: Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd  
Tel: 18502726233; 18502726233
Email: 3641133981@qq.com
Products Intro: Product Name:Resmethrin
CAS:1407166-95-3
Purity:95%+ HPLC Package:10mg;25mg;50mg;100mg;200mg
Company Name: United States Biological  
Tel: 1-800-520-3011
Email: sales@advtechind.com
Products Intro: Product Name:Dolutegravir-d6
Dolutegravir-d6 Basic information
Product Name:Dolutegravir-d6
Synonyms:Dolutegravir-d6
CAS:1407166-95-3
MF:C20H19F2N3O5
MW:419.38
EINECS:
Product Categories:
Mol File:1407166-95-3.mol
Dolutegravir-d6 Structure
Dolutegravir-d6 Chemical Properties
Safety Information
MSDS Information
Dolutegravir-d6 Usage And Synthesis
UsesDolutegravir-d6 is an isotopic analog of Dolutegravir (D528800) which is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.
Dolutegravir-d6 Preparation Products And Raw materials
Tag:Dolutegravir-d6(1407166-95-3) Related Product Information